Consistent with the results from our study, a clinical trial previously described that the majority of 69 biomarkers tested decreased with anti-TB treatment of pulmonary TB patients, except for osteocalcin, MCP-1 and MCP-4, which were significantly increased (42). Here, CCL13 is linked to pulmonary tuberculosis.